We are committed to achieving the highest standards of ethical conduct and to ensuring that Worldwide Clinical Trials, its management, employees and others who may provide services on its behalf act in compliance with all applicable laws of the countries in which it operates.
Read our Global Anti-Corruption Policy here (PDF)
Worldwide Clinical Trials prohibits any form of discrimination or harassment on the basis of age, race, religion, national origin, disability, gender (including pregnancy and sexual harassment) or any other characteristic or status protected by applicable law, rule or ordinance, including but not limited to Title VII and any applicable state counterpart.
Read our Policy Against Discrimination and Harassment here (PDF)
Section 54 of the UK Modern Slavery Act of 2015 requires certain companies doing business in the UK to publish a statement on the efforts they have taken to prevent modern slavery from occurring within their business and their supply chains. In compliance with this act, Worldwide Clinical Trials Limited, on behalf of itself and its affiliates, publishes this statement for the current financial year ending December 31st, 2023.